Introduction: Antimicrobial resistance (AMR) is a major One Health challenge affecting animal and public health. Commercial broiler farms are important reservoirs of antimicrobial-resistant bacteria; however, comprehensive multicenter data on the prevalence and resistance patterns of multidrug-resistant (MDR) Escherichia coli in Iranian poultry remain scarce. This study aimed to determine the prevalence, antimicrobial resistance profile, and farm-level distribution of MDR E. coli in commercial broiler farms in Iran.
Materials and Methods: A cross-sectional study was conducted during 2025-2026 in 18 commercial broiler farms across major poultry-producing regions of Iran. Farms were selected using a multistage sampling strategy. Cloacal and fecal samples were collected from healthy and diseased flocks. A total of 412 samples were cultured, yielding 174 non-duplicate E. coli isolates confirmed by standard bacteriological and biochemical methods. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method according to CLSI guidelines. MDR was defined as resistance to at least three antimicrobial classes. Differences in resistance prevalence between farms were evaluated using the chi-square test (p < 0.05).
Results: Among the 174 isolates, 128 (73.6%) exhibited resistance to at least one antimicrobial agent, and 69 (39.7%) were classified as MDR. Resistance was highest to tetracyclines (64.4%), beta-lactams (60.3%), and sulfonamides (57.5%), followed by fluoroquinolones (32.2%) and aminoglycosides (23.0%). MDR isolates most frequently exhibited resistance to three (46.4%) or four (28.1%) antimicrobial classes. Farm-level MDR prevalence ranged from 21.7% to 56.4%, likely reflecting differences in antimicrobial usage, flock management, and biosecurity.
Conclusions: The high prevalence of AMR and MDR E. coli highlights commercial broiler farms as important reservoirs of resistant bacteria in Iran. These findings provide baseline data for national AMR surveillance and support antimicrobial stewardship programs, routine susceptibility testing, strengthened farm biosecurity, vaccination-based disease prevention, and prudent antimicrobial use to reduce the dissemination of resistant bacteria throughout the poultry production chain.